Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $13.39M in the twelve months ending June 30, 2025, down -50.68% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $22.27M, down -11.55%.

• Revenue (ttm): $13.39M
• Revenue Growth: -50.68%
• P/S Ratio: 19.82
• Revenue / Employee: $83,701
• Employees: 160
• Market Cap: 267.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	22.27M	-2.91M	-11.55%
Dec 31, 2023	25.18M	22.63M	886.81%
Dec 31, 2022	2.55M	2.31M	941.85%
Dec 31, 2021	244.90K	-65.35K	-21.06%
Dec 31, 2020	310.25K	-694.78K	-69.13%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.